Click here to sign in with or
Forget Password?
Learn more
share this!
Share
Twit
Share
Email
September 23, 2017
(HealthDay)—Although rare, diabetes insipidus (DI) can occur following discontinuation of vasopressin infusion for septic shock, according to a case study published online Sept. 11 in the Journal of Clinical Pharmacy & Therapeutics.
(adsbygoogle = window.adsbygoogle || []).push({});
H. Rana, M.D., from the Montefiore Medical Center in Bronx, N.Y., and colleagues present a case of DI following discontinuation of vasopressin infusion for septic shock.
The authors describe a 54-year-old man who presented with pneumonia progressing to septic shock, requiring norepinephrine and vasopressin for refractory hypotension. On three separate occasions the patient developed polyuria and severe hypernatremia upon discontinuation of vasopressin, with prompt recovery upon its resumption.
“The occurrence of DI upon the discontinuation of vasopressin infusion in critically ill patients appears to be rare, but its incidence may be underestimated due to a paucity of published reports. Patients with acute neurologic or neurosurgical conditions, and patients in septic shock, represent all cases reported to date,” the authors write. “The actual incidence of this phenomenon, as well as its underlying mechanism, remains to be elucidated.”
Explore further
Copyright © 2017 HealthDay. All rights reserved.
Facebook
Twitter
Email
Feedback to editors
13 hours ago
0
14 hours ago
1
Oct 11, 2022
4
Oct 10, 2022
0
Oct 07, 2022
1
5 hours ago
7 hours ago
7 hours ago
7 hours ago
7 hours ago
8 hours ago
8 hours ago
Aug 02, 2016
Mar 21, 2017
May 24, 2017
Oct 22, 2012
Jul 31, 2017
Mar 16, 2017
8 hours ago
11 hours ago
12 hours ago
10 hours ago
10 hours ago
11 hours ago
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.
Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we’ll never share your details to third parties.
More information Privacy policy
Daily science news on research developments and the latest scientific innovations
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use.